Formation Bio is launching a $600 million investment fund to acquire promising experimental medicines and move them through clinical trials faster using artificial intelligence. The New York-based biotech company is betting that the pharmaceutical industry’s biggest problem isn’t finding new […]
The post Formation Bio launches $600M fund to accelerate AI-powered drug development first appeared on Tech Startups.
